Literature DB >> 16695988

Stathmin is expressed by the proliferating hepatocytes during liver regeneration.

D C Rowlands1, R F Harrison, N A Jones, A Williams, S G Hubscher, G Brown.   

Abstract

Aim-To determine the liver cell populations that express the phylogenetically conserved cytosolic protein stathmin during liver regeneration.Methods-Double immunostaining for stathmin and the Ki67 antigen was performed on sections of formaldehyde fixed, paraffin wax embedded tissues from 31 liver specimens. These included a variety of disease conditions characterised by some degree of hepatocyte regeneration. Quantitative western blot analysis was performed on 22 of these specimens.Results-Variable amounts of stathmin protein were detected by western blotting in all of the specimens examined. Stathmin was not detected in three cases of histologically normal liver. On immunostaining, stathmin was demonstrated in a proportion of hepatocytes as well as lymphoid inflammatory cells and other tissue elements. In all cases most of these stathmin positive cells showed nuclear positivity for the Ki67 antigen.Conclusions-Stathmin is expressed by proliferating hepatocytes but not by resting hepatocytes. Thus, it is likely that the protein has a function important to cell proliferation as opposed to cell differentiation.

Entities:  

Year:  1995        PMID: 16695988      PMCID: PMC407931          DOI: 10.1136/mp.48.2.m88

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  27 in total

1.  Purification and characterization of a 19-kilodalton intracellular protein. An activation-regulated putative protein kinase C substrate of T lymphocytes.

Authors:  M Gullberg; K Noreus; G Brattsand; B Friedrich; V Shingler
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

2.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

Review 3.  Liver regeneration: molecular mechanisms of growth control.

Authors:  G K Michalopoulos
Journal:  FASEB J       Date:  1990-02-01       Impact factor: 5.191

4.  Changes in the phosphorylation status of a 19 kD cytosolic protein are linked to the growth arrest of HL-60 cells.

Authors:  N A Jones; J M Lord; G Brown
Journal:  Leuk Res       Date:  1992       Impact factor: 3.156

5.  Involvement of OP18 in cell proliferation.

Authors:  R F Melhem; J R Strahler; N Hailat; X X Zhu; S M Hanash
Journal:  Biochem Biophys Res Commun       Date:  1991-09-30       Impact factor: 3.575

6.  Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells.

Authors:  G Brattsand; G Roos; U Marklund; H Ueda; G Landberg; E Nånberg; P Sideras; M Gullberg
Journal:  Leukemia       Date:  1993-04       Impact factor: 11.528

7.  Widespread differentiation stage-specific expression of the gene encoding phosphoprotein p19 (metablastin) in mammalian cells.

Authors:  U K Schubart; J Xu; W Fan; G Cheng; H Goldstein; G Alpini; D A Shafritz; J A Amat; M Farooq; W T Norton
Journal:  Differentiation       Date:  1992-09       Impact factor: 3.880

8.  Phosphorylation of two cytosolic proteins. An early event of T-cell activation.

Authors:  J F Peyron; C Aussel; B Ferrua; H Häring; M Fehlmann
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

9.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

10.  Human peripheral lymphocyte growth regulation and response to phorbol esters is linked to synthesis and phosphorylation of the cytosolic protein, prosolin.

Authors:  H L Cooper; E McDuffie; R Braverman
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

View more
  5 in total

1.  Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling.

Authors:  Simon Schimmack; Andrew Taylor; Ben Lawrence; Hubertus Schmitz-Winnenthal; Lars Fischer; Markus W Büchler; Irvin M Modlin; Mark Kidd; Laura H Tang
Journal:  Tumour Biol       Date:  2014-09-30

2.  Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.

Authors:  Yufeng Tian; Isa Mambetsariev; Nicolene Sarich; Fanyong Meng; Anna A Birukova
Journal:  Biochim Biophys Acta       Date:  2014-10-27

3.  Stathmin is involved in S100A4-mediated regulation of cell cycle progression.

Authors:  F Cajone; G V Sherbet
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

4.  Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma.

Authors:  Yi-Hsin Tseng; Ya-Hui Huang; Tzu-Kang Lin; Sheng-Ming Wu; Hsiang-Cheng Chi; Chung-Ying Tsai; Ming-Ming Tsai; Yang-Hsiang Lin; Wei-Chun Chang; Ya-Ting Chang; Wei-Jan Chen; Kwang-Huei Lin
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

5.  SHP2 inhibition enhances Yes-associated protein-mediated liver regeneration in murine partial hepatectomy models.

Authors:  Ryan D Watkins; EeeLN H Buckarma; Jennifer L Tomlinson; Chantal E McCabe; Jennifer A Yonkus; Nathan W Werneburg; Rachel L Bayer; Patrick P Starlinger; Keith D Robertson; Chen Wang; Gregory J Gores; Rory L Smoot
Journal:  JCI Insight       Date:  2022-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.